WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to RonanRx Inc. from its Center for Drug Evaluation and Research:

* * *

Recipient: RonanRx, Inc. dba RonanRx, 1011 Old McDade Rd., Elgin, TX 78621, hello@ronanrx.com, United States, hello@ronanrx.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER